Mid-market healthcare dealmaking is showing clear signs of diversification, with opportunity sets spreading across biotechnology, medical services and pharmaceuticals rather than concentrating in mega-deals. The latest global healthcare merger and acquisitions (M&A) review by Baker Tilly International, produced in partnership with Mergermarket, shows that in 2025, medical assets led the charge, driven by ongoing industry fragmentation. Medical assets linked to hospital management, medical equipment, services and healthcare supply companies account for the largest share of activity (both in volume and value), as investors pursue roll-up strategies built around scalable platforms and bolt-on acquisitions.
Read the full article: Mid-Market Healthcare Sector Signals //
Source: https://www.bakertilly.global/insights/mid-market-healthcare-sector-signals